Laboratory of Mitochondrial Lipids

Research interests

Barth syndrome disease

Barth syndrome (BTHS) is a hereditary mitochondrial disorder characterized by a reduction in total cardiolipin and the accumulation of its precursor, monolysocardiolipin, resulting from the deficiency of the transacylase enzyme tafazzin. However, the molecular mechanisms underlying BTHS pathology remain inadequately understood. In our group, we characterized the double mutant pgc1Δtaz1Δ in Saccharomyces cerevisiae, lacking phosphatidylglycerol-specific phospholipase C and tafazzin, as a novel yeast model for BTHS. In contrast to the previously utilized taz1Δ mutant, this model exhibits an accumulation of phosphatidylglycerol, more closely mirroring the characteristics of human BTHS cells. Overall, our results show that the pgc1Δtaz1Δ mutant better mimics the cellular phenotype of BTHS patients than taz1Δ cells, both in terms of lipid composition and the degree of disruption of mitochondrial structure and function. This favors the new model for use in future studies. 

Attenuation of inflammation

Recognition of microbial infection and initiation of host defense responses is regulated by multiple mechanisms. One of the best-studied pattern recognition receptors is Toll-like receptor 4 (TLR4), a receptor for bacterial lipopolysaccharide (LPS). New discoveries identified high-affinity inhibitory interactions between lung surfactant anionic phospholipids and TLR2, TLR4, respiratory syncytial virus (RSV), and influenza A virus (IAV) suggest that anionic phospholipids play an important role in the regulation of both infectious and innate immune processes. In the project, we would like to use the fact that phosphatidylglycerol (PG) is a strong antiviral and antibacterial agent. Our goal is to influence the immune response and increase the synthesis of PG directly in cells by the action of a specific drug that would affect the regulation of PG biosynthetic pathways. Administration of a drug capable of increasing PG synthesis in individuals could effectively prevent LPS activation of TLR4 or attachment of the virus to cellular epithelium and significantly reduce the immune response and transmission of infectious particles.

Mitochondrial communication

In eukaryotic cells, mitochondria are constantly adapting to changes in the biological activity of the cell, i.e., changes in nutrient availability and environmental stresses. We propose a model in which this adaptation is mediated by lipids. Specifically, we show that mitochondrial phospholipids regulate the biosynthesis of cellular sphingolipids and vice versa. To do this, lipids move by free diffusion, which does not require energy and works under any condition. This model represents a simple way for the cell to coordinate mitochondrial structure and performance with the actual needs of overall cellular metabolism. Its simplicity makes it a universally applicable principle of cellular regulation.

People

Mgr. Mária Balážová, PhD. – vedúca skupiny
RNDr. Lenka Bábelová, PhD.
Mgr. Ivana Ďurišová – doktorandka
Mgr. Ingrid Zriniová – doktorandka

Selected publications